Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
10-Q is filed. Things are slowly getting better;
-Sales up last 12 mos 73.33%
-Gross Profit up last 12 months 66.6%
-Decrease in Stock Compensation by 11.3% year-over-year
-Research & Development expenses decreased by 70.3% Year-over-Year.
-General & Admin fees/expenses increased by 23.7%
-‘Other Expenses’ decreased by 74% Year-over-Year.
For sure! I’m still hoping this product takes off, I’m still invested, long term if need be
I’m hoping for the same thing Manny!
Disappointing to say the least. Hoping a company will purchase CBond. At least to acquire the Patents & Trademarks, id assume there’s value there.
Weeeeeerrrrbeeeeee!
Can you ask the hounds for clarification on what ‘smelling a rep” means, when you get a chance please? My hounds are old & crabby and their sniffers are broken.
Thanks for the quote Werbe! What do you mean by you ‘smell a rep?”
IRSA-Inversiones y Representaciones S.A. GDR (IRS). Wonder why this company would be issuing a press release for C Bonds earnings call?
Same here! Thanks for
The info Femto99
Yeah. Does that number include ALL Shareholders or just internal, affiliates, Employees & officers ? Sorry, OTC is new to me, trying to figure it out as I go. Any info is appreciated!
Yeah for sure. Should show a pretty significant increases in Gross Sales. Hoping it’s filed soon!
Item 8.01 Other Events.
On January 9, 2019 the Company entered into a non-binding Letter of Intent to acquire MB Research Labs. The acquisition is expected to be completed in the first quarter of 2019. MB Research is a specialty in vitro and in vivo Contract Research Organization led by George DeGeorge, PhD. DABT. This GLP contract research laboratory has been conducting acute, subchronic and chronic toxicological and pharmacological studies since 1972. MB Research provides toxicology services for the pharmaceutical, biotechnology, medical device, cosmetics, consumer products and agrochemical industries as well as government agencies. Routine and non-traditional toxicology studies are performed, including customized protocols to meet specific research and testing needs. Study directors, scientists and technicians strive to consistently deliver exemplary service to support FDA, EPA, OECD, ISO and other regulatory agency guideline studies. The company is headquartered in Spinnerstown, Pennsylvania.
10K and 8K filed
I agree
Maybe the speculation is true!
You’re awesome. Thanks!
Femto99. Regarding Eastman, News article, Press release ?
$$$$$$. BOOM
Is SOAN Moving yet ?
Good stuff. Hoping to see a significant increase in Earnings by 2nd/3rd Quarter!
I’m in! C-bond has a really solid product. Might have a hidden gem here.